Spine

CORRECTED: NuVasive Seeks New Trial In Bid To Nix $30M IP Verdict

By Brandon Lowrey

Law360, Los Angeles (August 04, 2014, 10:06 PM ET) — NuVasive Inc. urged a California federal judge on Monday to throw out a jury’s $30 million verdict against it and grant a third trademark infringement trial over its use of the word “neurovision,” saying the award was excessive and rival Neurovision Medical Products Inc. improperly described barred evidence to jurors.

During a hearing in Los Angeles, NuVasive attorney William S. Boggs of DLA Piper called the jury’s $30 million award “an arbitrary deprivation of property” that goes beyond compensatory damages and represents far more than the…

READ THE REST HERE (SUBSCRIPTION REQUIRED)

Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close